Peritoneal Cancer Index (PCI)
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۳
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Scored0–39
The Peritoneal Cancer Index (PCI) calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include r0 central. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Peritoneal Cancer Index (Sugarbaker): 13 abdominopelvic regions each scored by largest lesion — LS-0 none, LS-1 <0.5 cm, LS-2 0.5-5 cm, LS-3 >5 cm or confluence; total 0-39. Higher = greater tumor burden; guides cytoreduction/HIPEC decisions.
Clinical Indication
The Peritoneal Cancer Index (PCI) is indicated for bedside clinical practice to support Peritoneal Cancer Index (Sugarbaker): 13 abdominopelvic regions each scored by largest lesion — LS-0 none, LS-1 <0.5 cm, LS-2 0.5-5 cm, LS-3 >5 cm or confluence; total 0-39. Higher = greater tumor burden; guides cytoreduction/HIPEC decisions.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.
Limitations & Contraindications
Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.
Clinical Pearls & Action Plan
Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.
PCI = sum of 13 regional lesion-size scores (0-3).
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| r0_central | integer | Yes | Central (0-3) |
| r1_ruq | integer | Yes | Right upper quadrant (0-3) |
| r2_epigastrium | integer | Yes | Epigastrium (0-3) |
| r3_luq | integer | Yes | Left upper quadrant (0-3) |
| r4_left_flank | integer | Yes | Left flank (0-3) |
| r5_left_lower | integer | Yes | Left lower (0-3) |
| r6_pelvis | integer | Yes | Pelvis (0-3) |
| r7_right_lower | integer | Yes | Right lower (0-3) |
| r8_right_flank | integer | Yes | Right flank (0-3) |
| r9_upper_jejunum | integer | Yes | Upper jejunum (0-3) |
| r10_lower_jejunum | integer | Yes | Lower jejunum (0-3) |
| r11_upper_ileum | integer | Yes | Upper ileum (0-3) |
| r12_lower_ileum | integer | Yes | Lower ileum (0-3) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–39 | Scored | PCI total |
Evidence-Based References (EBM)
- Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29-42.
- Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359-374.